Nanotechnology in the management of cervical cancer
File version
Author(s)
Gu, Wenyi
Yang, Lei
Chen, Chen
Shao, Renfu
Xu, Kewei
Xu, Zhi Ping
Griffith University Author(s)
Primary Supervisor
Other Supervisors
Editor(s)
Date
Size
File type(s)
Location
License
Abstract
Cervical cancer is a major disease with high mortality. All cervical cancers are caused by infection with human papillomaviruses (HPV). Although preventive vaccines for cervical cancer are successful, treatment of cervical cancer is far less satisfactory because of multidrug resistance and side effects. In this review, we summarize the recent application of nanotechnology to the diagnosis and treatment of cervical cancer as well as the development of HPV vaccines. Early detection of cervical cancer enables tumours to be efficiently removed by surgical procedures, leading to increased survival rate. The current method of detecting cervical cancer by Pap smear can only achieve 50% sensitivity, whereas nanotechnology has been used to detect HPVs with greatly improved sensitivity. In cervical cancer treatment, nanotechnology has been used for the delivery of anticancer drugs to increase treatment efficacy and decrease side effects. Nanodelivery of HPV preventive and therapeutic vaccines has also been investigated to increase vaccine efficacy. Overall, these developments suggest that nanoparticle-based vaccine may become the most effective way to prevent and treat cervical cancer, assisted or combined with some other nanotechnology-based therapy.
Journal Title
Reviews in Medical Virology
Conference Title
Book Title
Edition
Volume
25
Issue
S1
Thesis Type
Degree Program
School
Publisher link
DOI
Patent number
Funder(s)
Grant identifier(s)
Rights Statement
Rights Statement
Item Access Status
Note
Access the data
Related item(s)
Subject
Medical microbiology
Science & Technology
Life Sciences & Biomedicine
Virology
PHASE-II TRIAL
DRUG-DELIVERY
Persistent link to this record
Citation
Chen, J; Gu, W; Yang, L; Chen, C; Shao, R; Xu, K; Xu, ZP, Nanotechnology in the management of cervical cancer, Reviews in Medical Virology, 2015, 25 (S1), pp. 72-83